The Biotech Growth Trust PLC
BIOG.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | -0.12 | -0.01 |
| FCF Yield | -0.98% | -1.25% | -0.80% | -0.71% |
| EV / EBITDA | 4.07 | -2.61 | 44.57 | 0.00 |
| Quality | ||||
| ROIC | 24.03% | -38.90% | 2.10% | 21.84% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 96.44% |
| Cash Conversion Ratio | -0.04 | 0.03 | -0.33 | -0.03 |
| Growth | ||||
| Revenue 3-Year CAGR | -30.19% | -75.34% | -59.84% | -21.21% |
| Free Cash Flow Growth | 15.54% | -10.29% | -14.06% | 1.13% |
| Safety | ||||
| Net Debt / EBITDA | 0.40 | 0.10 | 4.20 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 10.37 | -29.76 | 233.59 | 9.73 |